XENE Stock Analysis: Buy, Sell, or Hold?
XENE - Xenon Pharmaceuticals Inc
$60.77
1.04 (1.74%)
▲
5d:
-2.53%
30d:
-7.11%
90d:
+12.29%
HOLD
MODERATE Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 10, 2026
0d
Get Alerted When XENE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: XENE shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: XENE shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: XENE is currently trading at $60.77, which is considered oversold relative to its 30-day fair value range of $63.12 to $66.91.
Technical Outlook: Technically, XENE is in a uptrend. The price is currently testing key support at $59.27. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 52/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $81.30 (+36.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, XENE is in a uptrend. The price is currently testing key support at $59.27. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 52/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $81.30 (+36.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$63.12 -
$66.91
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
Protect Your Profits
Holding XENE? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (52/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 36.1% below Wall St target ($81.30)
- NEUTRAL: Bottoming setup forming (52/100) — watch for confirmation
Trading Range Analysis
30-Day Trading Range
$63.12 -
$66.91
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$59.27
Resistance Level
$65.70
Current Trend
Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-12.28
Wall Street Target
$81.30
(+36.1%)
Revenue Growth (YoY)
-100.0%
Share & Embed Analysis
Last updated: August 22, 2026 2:26 PM ET
Data refreshes hourly during market hours. Next update: 3:26 PM
Data refreshes hourly during market hours. Next update: 3:26 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is XENE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
7
Sells
Net
INSIDERS SELLING
Recent Transactions
Andrea Difabio
SELL
1342 shares
2026-03-13
Christopher John Kenney
SELL
1410 shares
2026-03-13
Ian Mortimer
SELL
7308 shares
2026-03-13
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$91 | 42 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$285 | 66 BUY |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$35 | 50 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$108 | 52 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$125 | 41 HOLD |
Advanced XENE Option Strategies
Professional options setups generated by AI based on today's XENE price and gamma walls.